The Scientist

» misconduct and developmental biology

Most Recent

Colleagues of the surgeon under investigation distance themselves from a 2011 The Lancet study.

0 Comments

image: A Gut Feeling

A Gut Feeling

By | April 1, 2016

See profilee Hans Clevers discuss his work with stem cells and cancer in the small intestine.

0 Comments

image: Guts and Glory

Guts and Glory

By | April 1, 2016

An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.

1 Comment

image: Karolinska Lets Macchiarini Go

Karolinska Lets Macchiarini Go

By | March 24, 2016

The embattled artificial organ researcher has been dismissed over the fallout from several misconduct allegations leveled against him.

0 Comments

image: Macchiarini Coauthor Removed From Paper

Macchiarini Coauthor Removed From Paper

By | March 7, 2016

A whistleblower asked to have his named pulled from a study led by the embattled surgeon.

1 Comment

image: Author Nets Seven Retractions

Author Nets Seven Retractions

By | February 22, 2016

Biochemical Pharmacology pulls papers coauthored by a scientist whose work has been under investigation at MD Anderson Cancer Center.

0 Comments

image: Adjustable Brain Cells

Adjustable Brain Cells

By | February 18, 2016

Neighboring neurons can manipulate astrocytes. 

1 Comment

image: Karolinska Institute Head Steps Down

Karolinska Institute Head Steps Down

By | February 16, 2016

Vice-Chancellor Anders Hamsten is resigning from his post amidst another investigation into the work of surgeon Paolo Macchiarini.

1 Comment

image: Chemist Sues University Again

Chemist Sues University Again

By | February 11, 2016

Suvi Orr has filed suit against the University of Texas for the second time in two years in an attempt to prevent the school from revoking her PhD.

0 Comments

image: Organ Engineer Reinvestigated

Organ Engineer Reinvestigated

By | February 5, 2016

Paolo Macchiarini will again be investigated by the Karolinska Institute, which is not extending the researcher’s employment contract.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS